VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
IRLA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
IRLAIRulya Therapeutics Inc.
$40.59$39M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksIRLAQuarterly Cash Flow

IRulya Therapeutics Inc. (IRLA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

IRulya Therapeutics Inc. (IRLA) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

IRLA Cash Flow Statement

Quarterly statement

IRLA Cash Flow Statement

IRulya Therapeutics Inc. (IRLA) cash flow statement — 9-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-9.84M-18.89M-7.63M-10.48M-9.93M-11.41M-9.6M-7.55M-7.26M-8.74M-8.35M-6.08M-4.82M-3.83M-3.57M-5.83M-6.7M-15.41M-16.09M-14.42M
Operating CF Margin %--------------------
Operating CF Growth %0.89%-65.46%20.56%-38.78%-36.75%-30.62%-----134.04%-4.16%28.06%75.17%77.82%59.53%61.38%12.23%-18.23%-8.6%
Net Income-27.74M-75.49M35.91M-39.46M-13.44M-16.05M-15.03M-12.46M-5.49M-27.73M-11.15M-8.89M-5.35M-4.89M-12.25M-5.53M-7.92M-16.56M-21.64M-23.4M
Depreciation & Amortization15K41K36K39K36K35K32K16K86K44K40K304K01K17K42K40K84K38K84K
Stock-Based Compensation1.64M12.09M1.29M1.19M1.25M1.27M1.39M1.13M1.12M1.22M1.27M1.09M1.33M1.32M1.48M1.63M694K5.05M9.24M8.49M
Deferred Taxes00000000000-1.82M00-248K00-284K00
Other Non-Cash Items12M52.05M-30.41M15.28M2.03M5.2M1.96M1.87M-2.83M19.14M2.29M3M-719K-465K5.83M-208K771K215K135K199K
Working Capital Changes4.25M-7.58M-14.45M12.47M194K-1.87M2.05M1.9M-152K-1.42M-805K250K-79K201K1.6M-1.77M-281K-3.92M-3.86M205K
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables-3.02M260K5.91M-1.15M1.63M-1.44M22K1.35M-825K342K59K-127K55K-1.3M1.08M-614K-665K-3.48M-1.18M2.03M
Cash from Investing-67.79M8M12M8.07M-1.78M6.04M10.9M10.87M7.11M-4.98M8.91M5.39M3.63M-20.32M5.54M18.67M-8.83M-5.25M13.41M20.92M
Capital Expenditures-71K00-4K-74K-126K-148K-133K-46K-39K-39K-24K00-136K-78K-50K0-5K-44K
CapEx % of Revenue--------------------
Acquisitions-2.8M8M000000000-2.12M000000135K0
Investments--------------------
Other Investing480K62K0000355K490K000-500K-500K090K035K10.63M-135K0
Cash from Financing-10K108.93M9.44M2.03M1.38M14.41M87K0-5M35K190K57K10K26K50K-18K-5K108K622K990K
Debt Issued (Net)00-5.54M00000000-6K00-6K-18K-19K-12K00
Equity Issued (Net)0108.99M14.99M2.03M1.38M14.41M87K0035K190K57K10K26K0000608K990K
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing-10K-56K000000-5M006K0056K014K120K14K0
Net Change in Cash-76.16M97.82M12.35M-643K-10.37M9.05M1.56M3.54M-5.21M-13.92M1.06M-880K-1.02M-24.06M2.13M12.77M-15.12M-20.64M-2.16M7.52M
Free Cash Flow-9.91M-18.89M-7.63M-10.48M-10M-11.54M-9.75M-7.68M-7.31M-8.78M-8.39M-6.1M-4.82M-3.83M-3.71M-5.91M-6.75M-15.41M-16.1M-14.46M
FCF Margin %--------------------
FCF Growth %0.91%-63.65%21.77%-36.43%-36.9%-31.48%-----126.5%-3.2%28.59%75.17%76.98%59.11%61.09%12.72%-17.95%-8.85%
FCF per Share-0.83-3.08-30.45-41.86-37.08-49.44-44.37-35.53-33.85-40.74-39.02-29.79-26.71-21.31-20.67-32.73-37.89-94.96-106.83-97.17
FCF Conversion (FCF/Net Income)0.35x0.25x-0.21x0.27x0.74x0.71x0.64x0.61x1.32x0.32x0.75x0.68x0.90x0.78x0.29x1.05x0.85x0.93x0.74x0.62x
Interest Paid0000064K00000000000000
Taxes Paid00000000000000000000